As of June 2026, 8 paid clinical trials are recruiting for Oncology in Long Island City, New York. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Long Island City has approximately 23 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Researchers run research studies in Long Island City, NY at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NYC Research INC | Obesity, Overweight, Osteoarthritis | 4 |
| Memorial Sloan Kettering Cancer Center | Lung Cancer - Non Small Cell Non-Squamous, Lung Cancer - Non Small Cell Squamous, Metastatic Head and Neck Cancer | 2 |
| Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 2 |
| David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center | Solid Tumor, Adult | 1 |
| Investigational Drug Service | Advanced Breast Cancer, Advanced Gastric Cancer, Breast Neoplasms | 1 |
| Long Island Vitreoretinal Consultants - Westbury | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| MSK Cancer Center | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 1 |
| Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy | Urothelial Carcinoma | 1 |
| Memorial Sloan Kettering | Metastatic HER2-positive Breast Cancer | 1 |
| Memorial Sloan Kettering Cancer Center (IDS Pharmacy) | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 1 |
| Memorial Sloan Kettering Cancer Center - Main | Leukemia | 1 |
| Mount Sinai Queens | Clostridioides Difficile Associated Disease | 1 |
| NYC Research Inc. | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| Northwell Health | GBM, Glioblastoma | 1 |
| Research Site 156 | Hypertriglyceridemia | 1 |
| Research Site 72 | Hypertriglyceridemia | 1 |
| START | GI Cancers | 1 |
| Site Number - 1032 | Graves' Disease | 1 |
Recruiting trials in Long Island City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Hipa.ai aggregates every recruiting study in Long Island City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 23 recruiting clinical trials in Long Island City, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Long Island City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Long Island City include Obesity (2), Overweight (2), Advanced Breast Cancer (1), Advanced Gastric Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Long Island City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Long Island City include NYC Research INC, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Long Island City are Cancer & tumors (10), Diabetes & metabolic (6), Eye & vision (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.